Comparing scorpion antivenom alone versus with prazosin for scorpion sting treatment
Official title: A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin Drug for Scorpion Stings Management in Sohag University Hospitals
Run by Sohag University · NCT06287905 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests whether adding prazosin to scorpion antivenom helps people who have been stung by scorpions feel better and recover faster in the hospital.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 1 Year to 70 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06287905 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a clinical diagnosis of scorpion sting admitted to Sohag University Hospitals.
✕Probably not a fit
Patients with other types of envenomation or poisoning will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the effectiveness of scorpion antivenom alone compared to a combination of scorpion antivenom and prazosin in patients admitted to Sohag University Hospitals due to scorpion stings. Patients will be randomized into two groups: one receiving only antivenom and the other receiving both antivenom and prazosin. The study will monitor vital signs, clinical outcomes, and duration of hospital stay to assess the impact of the treatments. Proper first aid and supportive care will be provided to all participants.
Why it matters
Potential benefit: If successful, this study could improve treatment outcomes and reduce mortality rates in patients suffering from scorpion stings.
How similar studies have gone: While the combination of antivenom and prazosin is a novel approach, previous studies have shown the effectiveness of antivenom in treating scorpion stings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * History and clinical diagnosis of scorpion sting * Admit in Sohag University hospitals * During the period from February 2023 to July 2024. * Accepting informed written consent from the case itself or the first degree relative if the case will underage or in a coma. Exclusion Criteria: * .All other envenomation cases or poisoning will be excluded.
Where it's running
-
Meray Medhat Shokry Zaghary
Sohag, Egypt Recruiting
Study contacts
- Principal investigator: Meray M Shokry Zaghary — Sohag University
- Study coordinator: Meray M Shokry Zaghary, PhD
- Email: drevanho2013@gmail.com
- Phone: +201028911003
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
R21/Matrix-M malaria vaccine: effectiveness and safety in children
This project will try to see if the R21/Matrix‑M vaccine lowers severe and clinical P. falciparum malaria in children and whether vaccinated children have a different risk of death.
-
Effect of Traditional Chinese Medicine on Organ Failure in Critically Ill Patients
This study is testing whether traditional Chinese medicine can help critically ill patients with organ failure in the ICU feel better and recover faster.
-
Examining the effects of bariatric surgery on heart disease and mortality
This study is trying to see if different types of weight-loss surgery can help people with obesity lower their risk of heart disease and live longer compared to those who don't have surgery.
-
Evaluating medical oxygen access and policies
This study looks at how access to medical oxygen works in six countries to see what challenges people face and how to improve it for patients and healthcare providers.
-
Evaluation of a multi-country medical oxygen program
This study is trying to see how medical oxygen is used in hospitals across nine countries to find ways to make it easier for patients, especially children with low oxygen levels, to get the help they need.
-
Registry for patients with chronic hypoparathyroidism
This study looks at how living with chronic hypoparathyroidism affects patients' overall health and quality of life over time, by comparing their experiences with those of similar people without the condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.